37 results on '"Luque, Marco"'
Search Results
2. Neurodevelopmental assessment of normocephalic children born to Zika virus exposed and unexposed pregnant people
- Author
-
Alger, Jackeline, primary, Cafferata, María Luisa, additional, López, Raquel, additional, Wiggins, Lisa D., additional, Callejas, Allison, additional, Castillo, Mario, additional, Fúnes, Jenny, additional, Rico, Fátima, additional, Valencia, Diana, additional, Varela, Douglas, additional, Alvarez, Zulma, additional, Berrueta, Mabel, additional, Bock, Harry, additional, Bustillo, Carolina, additional, Calderón, Alejandra, additional, Ciganda, Alvaro, additional, García-Aguilar, Jorge, additional, García, Kimberly, additional, Gibbons, Luz, additional, Gilboa, Suzanne M., additional, Harville, Emily W., additional, Hernández, Gustavo, additional, López, Wendy, additional, Lorenzana, Ivette, additional, Luque, Marco T., additional, Maldonado, Carlos, additional, Moore, Cynthia, additional, Ochoa, Carlos, additional, Parham, Leda, additional, Pastrana, Karla, additional, Paternina-Caicedo, Angel, additional, Rodríguez, Heriberto, additional, Stella, Candela, additional, Tannis, Ayzsa F., additional, Wesson, Dawn M., additional, Zúniga, Concepción, additional, Tong, Van T., additional, and Buekens, Pierre, additional
- Published
- 2023
- Full Text
- View/download PDF
3. Enhancing global vaccine pharmacovigilance: Proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination
- Author
-
Kuli-Lito, Georgina, Kostaqi, Entela, Petrela, Elizana, Castellano, Vanesa E., Chiarvetti, Lucia, Falcó, Adriana, Gentile, Angela, Guirau, Karina, Carrega, Maria Eugenia Pérez, Rasjido, Susana, Testino, Sofía, Vizzotti, Carla, Buttery, Jim, Mcminn, Alissa, Quinn, Julie, Avendaño, Marcela, González, Marcela, Lagos, Rosanna, Maturana, Marcelo, Muñoz, Fernando, Saldaña, Adiela, Soza, Guillermo, Zhang, Tao, Zhang, Xiyan, Ding, Yunfang, Zhang, Jun, Alvarez-Olmos, Martha I., Sastoque, Luz Amparo, Mezerville, Marcela Hernández-de, Machado, Vicenta, Roverssi, Ileana, Camacho, Angélica Vargas, Luque, Marco Tulio, Mendoza, Liset, Ravi, Mandyam, Manjunath, V.G., Karimi, Abdollah, Ghanaie, Roxana Mansour, Seifi, Kimia, Shirvani, Fariba, Ashrafi, Mahmoud Reza, Parvaneh, Nima, Kochakzadeh, Leily, Mamishi, Sertareh, Kompani, Farzad, Eshaghi, Hamid, Pirmoazen, Vahideh, Aquije Hernández, Renne F., Díaz, Maria Esther Castillo, Mamani, Gladys Turpo, Thoon, Koh Cheng, Oh, Bee Khiam, Yelen, Cutland, Clare, Madhi, Shabir A., Groome, Michelle, Velaphi, Sithembiso, Izu, Alane, Diep, Linh, Hwinya, Cleopas, Pérez-Vilar, Silvia, Díez-Domingo, Javier, Martín-Navarro, Marian, Soriano-García, Esther, Tuells, Jose, Pande, Stephen Legesi, Alaroker, Florence, Amulen, Dorothy, Akareut, Margaret, Areto, Esther, Komo, Richard Samson, Quinto, Ogwang, Giachetto, Gustavo, Speranza, Noelia, Zunino, Carlos, Perez-Vilar, Silvia, Weibel, Daniel, Sturkenboom, Miriam, Black, Steven, Maure, Christine, Castro, Jose Luis, Bravo-Alcántara, Pamela, Dodd, Caitlin N., Romio, Silvana A., de Ridder, Maria, Nakato, Swabra, Molina-León, Helvert Felipe, Elango, Varalakshmi, and Zuber, Patrick L.F.
- Published
- 2018
- Full Text
- View/download PDF
4. Operational lessons learned in conducting a multi-country collaboration for vaccine safety signal verification and hypothesis testing: The global vaccine safety multi country collaboration initiative
- Author
-
Kuli-Lito, Georgina, Kostaqi, Entela, Petrela, Elizana, Castellano, Vanesa E., Chiarvetti, Lucia, Falcó, Adriana, Gentile, Angela, Guirau, Karina, Carrega, Maria Eugenia Pérez, Rasjido, Susana, Testino, Sofía, Vizzotti, Carla, Buttery, Jim, Mcminn, Alissa, Quinn, Julie, Avendaño, Marcela, González, Marcela, Lagos, Rosanna, Maturana, Marcelo, Muñoz, Fernando, Saldaña, Adiela, Soza, Guillermo, Zhang, Tao, Zhang, Xiyan, Ding, Yunfang, Zhang, Jun, Alvarez-Olmos, Martha I., Sastoque, Luz Amparo, Mezerville, Marcela Hernández-de, Machado, Vicenta, Roverssi, Ileana, Camacho, Angélica Vargas, Luque, Marco Tulio, Mendoza, Liset, Ravi, Mandyam, Manjunath, V.G., Karimi, Abdollah, Ghanaie, Roxana Mansour, Seifi, Kimia, Shirvani, Fariba, Ashrafi, Mahmoud Reza, Parvaneh, Nima, Kochakzadeh, Leily, Mamishi, Sertareh, Kompani, Farzad, Eshaghi, Hamid, Pirmoazen, Vahideh, Aquije Hernández, Renne F., Díaz, Maria Esther Castillo, Mamani, Gladys Turpo, Thoon, Koh Cheng, Oh, Bee Khiam, Yelen, Cutland, Clare, Madhi, Shabir A., Groome, Michelle, Velaphi, Sithembiso, Izu, Alane, Diep, Linh, Hwinya, Cleopas, Pérez-Vilar, Silvia, Díez-Domingo, Javier, Martín-Navarro, Marian, Soriano-García, Esther, Pande, Stephen Legesi, Alaroker, Florence, Amulen, Dorothy, Akareut, Margaret, Areto, Esther, Komo, Richard Samson, Quinto, Ogwang, Giachetto, Gustavo, Speranza, Noelia, Zunino, Carlos, Guillard-Maure, Christine, Elango, Varalakshmi, Black, Steven, Perez-Vilar, Silvia, Castro, Jose Luis, Bravo-Alcántara, Pamela, Molina-León, Helvert Felipe, Weibel, Daniel, Sturkenboom, Miriam, and Zuber, Patrick L.F.
- Published
- 2018
- Full Text
- View/download PDF
5. Building capacity for active surveillance of vaccine adverse events in the Americas: A hospital-based multi-country network
- Author
-
Castellano, Vanesa E., Chiarvetti, Lucia, Falcó, Adriana, Gentile, Angela, Guirau, Karina, Carrega, Maria Eugenia Pérez, Rasjido, Susana, Testino, Sofía, Vizzotti, Carla, Avendaño, Marcela, González, Marcela, Lagos, Rosanna, Maturana, Marcelo, Muñoz, Fernando, Saldaña, Adiela, Soza, Guillermo, Álvarez-Olmos, Martha, Sastoque, Luz Amparo, Mezerville, Marcela Hernández-de, Machado, Vicenta, Roverssi, Ileana, Camacho, Angélica Vargas, Luque, Marco Tulio, Mendoza, Liset, Hernández, Renne F. Aquije, Díaz, Maria Esther Castillo, Mamani, Gladys Turpo, Giachetto, Gustavo, Speranza, Noelia, Zunino, Carlos, Bravo-Alcántara, Pamela, Pérez-Vilar, Silvia, Molina-León, Helvert Felipe, Sturkenboom, Miriam, Black, Steven, Zuber, Patrick L.F., Maure, Christine, and Castro, Jose Luis
- Published
- 2018
- Full Text
- View/download PDF
6. Simplifying screening for Trypanosoma cruzi in pregnant persons and their infants
- Author
-
Buekens, Pierre, primary, Alger, Jackeline, additional, Cafferata, Maria Luisa, additional, Dumonteil, Eric, additional, Herrera, Claudia, additional, Tulio Luque, Marco, additional, and Carlier, Yves, additional
- Published
- 2023
- Full Text
- View/download PDF
7. Mortality in Children with Human Immunodeficiency Virus Initiating Treatment: A Six-Cohort Study in Latin America
- Author
-
Luque, Marco T., Jenkins, Cathy A., Shepherd, Bryan E., Padgett, Denis, Rouzier, Vanessa, Succi, Regina Célia M., Machado, Daisy M., McGowan, Catherine C., Vermund, Sten H., and Pinto, Jorge A.
- Published
- 2017
- Full Text
- View/download PDF
8. Sex-based differences in antiretroviral therapy initiation, switching and treatment interruptions: global overview from the International Epidemiologic Databases to Evaluate AIDS (IeDEA)
- Author
-
Giles, Michelle L, Achhra, Amit C, Abraham, Alison G, Haas, Andreas D, Gill, Michael John, Lee, Man Po, Luque, Marco, McGowan, Catherine, Cornell, Morna, Braitstein, Paula, de Rekeneire, Nathalie, Becquet, Renaud, Wools-Kaloustian, Kara, and Law, Matthew
- Subjects
HIV infections -- Drug therapy -- Research ,Antiretroviral agents -- Dosage and administration ,Sex differences (Biology) -- Research ,Health - Abstract
Introduction: In 2015, the World Health Organization recommended that all HIV-infected individuals consider ART initiation as soon as possible after diagnosis. Sex differences in choice of initial ART regimen, indications for switching, time to switching and choice of second-line regimens have not been well described. The aims of this study were to describe first-line ART and CD4 count at ART initiation by sex, calendar year and region, and to analyse time to change or interruption in first-line ART, according to sex in each region. Methods: Participating cohorts included: Southern, East and West Africa (IeDEA-Africa), North America (NA-ACCORD), Caribbean, Central/South America (CCASAnet) and Asia-Pacific including Australia (IeDEA Asia-Pacific). The primary outcomes analysed for each region and according to sex were choice of initial ART, time to switching and time to discontinuation of the first-line regimen. Results and Discussion: The combined cohort data set comprised of 715,252 participants across seven regions from low- to high-income settings. The median CD4 count at treatment initiation was lower in men compared with women in nearly all regions and time periods. Women from North America and Southern Africa were more likely to switch ART compared to men (p < 0.001) with approximately 90% of women reporting a major change after 10 years in North America. Overall, after 8 years on ART, >50% of HIV- positive men and women from Southern Africa, East Africa, South and Central America remained on their original regimen. Men were more likely to have a treatment interruption compared with women in low- and middle-income countries from the Asia/Pacific region (p < 0.001) as were men from Southern Africa (p < 0.001). Greater than 75% of men and women did not report a treatment interruption after 10 years on ART from all regions except North America and Southern Africa. Conclusions: There are regional variations in the ART regimen commenced at baseline and rates of major change and treatment interruption according to sex. Some of this is likely to reflect changes in local and international antiretroviral guideline recommendations but other sex-specific factors such as pregnancy may contribute to these differences. Keywords: cohort studies; gender; treatment; women; sex; HIV, 1 | INTRODUCTION Over the past decade, HIV treatment guidelines have changed, with the CD[4.sup.+] count threshold for initiating antiretroviral therapy (ART) gradually increasing from less than 350 cells/[micro]L in [...]
- Published
- 2018
- Full Text
- View/download PDF
9. Integration of HIV care into maternal and child health services in the global IeDEA consortium
- Author
-
Humphrey, John, primary, Nagel, Elizabeth, additional, Carlucci, James G., additional, Edmonds, Andrew, additional, Kinikar, Aarti, additional, Anderson, Kim, additional, Leroy, Valériane, additional, Machado, Daisy, additional, Yin, Dwight E., additional, Tulio Luque, Marco, additional, Amorissani-Folquet, Madeleine, additional, Mbewe, Safari, additional, Suwanlerk, Tulathip, additional, Munyaneza, Athanase, additional, Patel, Rena C., additional, Musick, Beverly, additional, Abuogi, Lisa, additional, and Wools-Kaloustian, Kara, additional
- Published
- 2023
- Full Text
- View/download PDF
10. Zika virus in Pregnancy in a Honduran cohort: neurodevelopmental assessment of normocephalic children born to Zika virus exposed and non-exposed pregnant people
- Author
-
Alger, Jackeline, primary, Cafferata, María Luisa, additional, López, Raquel, additional, Wiggins, Lisa D., additional, Callejas, Allison, additional, Castillo, Mario, additional, Fúnes, Jenny, additional, Rico, Fátima, additional, Valencia, Diana, additional, Varela, Douglas, additional, Alvarez, Zulma, additional, Berrueta, Mabel, additional, Bock, Harry, additional, Bustillo, Carolina, additional, Calderón, Alejandra, additional, Ciganda, Alvaro, additional, García, Jorge, additional, García, Kimberly, additional, Gibbons, Luz, additional, Gilboa, Suzanne M., additional, Harville, Emily W., additional, Hernández, Gustavo, additional, López, Wendy, additional, Lorenzana, Ivette, additional, Luque, Marco T., additional, Maldonado, Carlos, additional, Moore, Cynthia, additional, Ochoa, Carlos, additional, Parham, Leda, additional, Pastrana, Karla, additional, Paternina-Caicedo, Angel, additional, Rodríguez, Heriberto, additional, Stella, Candela, additional, Tannis, Ayzsa F., additional, Wesson, Dawn, additional, Zúniga, Concepción, additional, Tong, Van T., additional, and Buekens, Pierre, additional
- Published
- 2023
- Full Text
- View/download PDF
11. Mixed candidemia in a pediatric patient with Hirschsprung's disease
- Author
-
Ortiz, Bryan, primary, Aguilar, Kateryn, additional, Luque, Marco, additional, Díaz, Kevin, additional, Galindo, Celeste, additional, Rivera, Daniel, additional, López, Roque, additional, and Fontecha, Gustavo, additional
- Published
- 2023
- Full Text
- View/download PDF
12. Simplifying screening for Trypanosoma cruzi in pregnant persons and their infants
- Author
-
Buekens, Pierre, Alger, Jackeline, Cafferata, Maria-Luisa, Dumonteil, Eric, Herrera, Claudia, Luque, Marco Tulio, Carlier, Yves, Buekens, Pierre, Alger, Jackeline, Cafferata, Maria-Luisa, Dumonteil, Eric, Herrera, Claudia, Luque, Marco Tulio, and Carlier, Yves
- Abstract
SCOPUS: ar.j, info:eu-repo/semantics/published
- Published
- 2023
13. Lessons learned from over a decade of data audits in international observational HIV cohorts in Latin America and East Africa
- Author
-
Lotspeich, Sarah C., primary, Shepherd, Bryan E., additional, Kariuki, Marion Achieng, additional, Wools-Kaloustian, Kara, additional, McGowan, Catherine C., additional, Musick, Beverly, additional, Semeere, Aggrey, additional, Crabtree Ramírez, Brenda E., additional, Mkwashapi, Denna M., additional, Cesar, Carina, additional, Ssemakadde, Matthew, additional, Machado, Daisy Maria, additional, Ngeresa, Antony, additional, Ferreira, Flávia Faleiro, additional, Lwali, Jerome, additional, Marcelin, Adias, additional, Cardoso, Sandra Wagner, additional, Luque, Marco Tulio, additional, Otero, Larissa, additional, Cortés, Claudia P., additional, and Duda, Stephany N., additional
- Published
- 2023
- Full Text
- View/download PDF
14. Esporotricosis en un Paciente Adolescente
- Author
-
Medina, Rina, primary, Flores, Jandy, additional, and Luque, Marco Tulio, additional
- Published
- 2021
- Full Text
- View/download PDF
15. Outcomes After Second-Line Antiretroviral Therapy in Children Living With HIV in Latin America
- Author
-
Somerville, Kayla, primary, Jenkins, Cathy A., additional, Carlucci, James G., additional, Person, Anna K., additional, Machado, Daisy M., additional, Luque, Marco T., additional, Pinto, Jorge A., additional, Rouzier, Vanessa, additional, Friedman, Ruth K., additional, McGowan, Catherine C., additional, Shepherd, Bryan E., additional, and Rebeiro, Peter F., additional
- Published
- 2021
- Full Text
- View/download PDF
16. Microcephaly Outcomes among Zika Virus–Infected Pregnant Women in Honduras
- Author
-
Alger, Jackeline, primary, Buekens, Pierre, additional, Cafferata, Maria Luisa, additional, Alvarez, Zulma, additional, Berrueta, Mabel, additional, Bock, Harry, additional, Bustillo, Carolina, additional, Calderón, Alejandra, additional, Callejas, Allison, additional, Castillo, Mario, additional, Ciganda, Alvaro, additional, Fúnes, Jenny, additional, García, Jorge, additional, García, Kimberly, additional, Gibbons, Luz, additional, Gilboa, Suzanne M., additional, Harville, Emily W., additional, Hernández, Gustavo, additional, López, Raquel, additional, López, Wendy, additional, Lorenzana, Ivette, additional, Tulio Luque, Marco, additional, Maldonado, Carlos, additional, Moore, Cynthia A., additional, Ochoa, Carlos, additional, Parham, Leda, additional, Pastrana, Karla, additional, Rico, Fátima, additional, Rodríguez, Heriberto, additional, Stella, Candela, additional, Valencia, Diana, additional, Varela, Douglas, additional, Wesson, Dawn M., additional, Zúniga, Concepción, additional, and Tong, Van T., additional
- Published
- 2021
- Full Text
- View/download PDF
17. Outcomes After Second-Line Antiretroviral Therapy in Children Living With HIV in Latin America.
- Author
-
Somerville, Kayla, Jenkins, Cathy A., Carlucci, James G., Person, Anna K., Machado, Daisy M., Luque, Marco T., Pinto, Jorge A., Rouzier, Vanessa, Friedman, Ruth K., McGowan, Catherine C., Shepherd, Bryan E., and Rebeiro, Peter F.
- Published
- 2022
- Full Text
- View/download PDF
18. #72: Implementing an Algorithm-based Approach for Treatment of Fever and Neutropenia in Pediatric Oncology Patients in Tegucigalpa, Honduras
- Author
-
Ordóñez, Sara, primary, Luque, Marco, additional, Zacasa, Pamela, additional, Fu, Ligia, additional, Peña, Armando, additional, Caniza, Miguela, additional, and Mukkada, Sheena, additional
- Published
- 2021
- Full Text
- View/download PDF
19. Improving Methods to Classify Perinatal versus Nonperinatal HIV Acquisition in Young Adolescents 10–14 Years of Age
- Author
-
Tsondai, Priscilla Ruvimbo, primary, Davies, Mary-Ann, additional, Singtoroj, Thida, additional, Maxwell, Nicola, additional, McGowan, Catherine C., additional, Songtaweesin, Wipaporn N., additional, Technau, Karl-Günter, additional, Kariminia, Azar, additional, Chimbetete, Cleophas, additional, Succi, Regina C. M., additional, Pinto, Jorge, additional, Rouzier, Vanessa, additional, Luque, Marco Tulio, additional, and Sohn, Annette H., additional
- Published
- 2021
- Full Text
- View/download PDF
20. Epidemiología del dengue en Centroamérica y República Dominicana
- Author
-
Ávila-Agüero, María L, Camacho-Badilla, Kattia, Brea-Del-Castillo, José, Cerezo, Lizbeth, Dueñas, Lourdes, Luque, Marco, Melgar, Mario, and Rocha, Crisanta
- Subjects
Dengue ,República Dominicana ,Dominican Republic ,incidence ,Centroamérica ,epidemiology ,Central America ,mortality ,incidencia ,letalidad ,epidemiología - Abstract
Resumen Introducción: Centroamérica experimenta una alta carga de la enfermedad por dengue aportando cerca de 8% de todos los casos del continente. Este trabajo reporta la epidemiología del dengue en la subregión en un período de 10 años. Objetivos: Documentar la epidemiología del dengue en Centro América y República Dominicana. Material y Métodos: Período de estudio: años 2005-2014. Se recopilaron y analizaron los datos de casos y muertes por dengue de los países de Centro América y República Dominicana, reportados por los Ministerios de Salud y se corroboró con los datos publicados en los boletines en línea y la base de datos interactiva de la Organización Panamericana de la Salud (OPS). Se obtuvieron estadísticas poblacionales de los Institutos Nacionales de Estadística y Censo de cada país. Resultados: Durante el período de estudio fueron notificados 1.118.464 casos de dengue. Reportados 32.431 casos graves, 888 personas fallecidas. La letalidad por caso de dengue fue en promedio 0,08%. Los cuatro serotipos de dengue circularon durante el decenio estudiado. Discusión: La información clínica y epidemiológica, indica tasas de incidencia alta, que han fluctuado en los últimos años, con co-circulación significativa de varios serotipos a la vez. Conclusiones: Se identificaron diferencias notorias en la recolección de datos de la vigilancia entre países. Se determinó un patrón epidemiológico heterogéneo. Background: Central America experiences a high burden of dengue reporting about 8% of all cases in the continent. This work reports the epidemiology of dengue in the sub region in a 10 years period. Aim: To describe the epidemiology of dengue in Central America and the Dominican Republic. Methods: Study period from 2005 to 2014. The data on dengue cases and deaths of the countries of Central America and the Dominican Republic, reported by the Ministries of Health, were compiled and analyzed and corroborated with the data published in the online bulletins and the interactive database of the Pan American Health Organization (PAHO). Population statistics were obtained from the National Statistics and Census Institutes of each country. Results: During the study period, 1,118,464 cases of dengue were notified. There were 32,431 serious cases reported, 888 people died. The lethality per case of dengue was on average 0.08%. The four dengue serotypes circulated during the decade analyzed. Discussion: Clinical and epidemiological information indicates high incidence rates, which have fluctuated in recent years, with significant co-circulation of several serotypes at the same time. Conclusions: Notorious surveillance data collection differences were identified between countries, determining a heterologous epidemiological pattern.
- Published
- 2019
21. Guidance Statement for the Management of Febrile Neutropenia in Pediatric Patients Receiving Cancer-Directed Therapy in Central America and the Caribbean
- Author
-
Melgar, Mario, primary, Reljic, Tea, additional, Barahona, Guillermo, additional, Camacho, Kattia, additional, Chang, Alicia, additional, Contreras, Johanny, additional, Espinoza, Darrell, additional, Estripeaut, Dora, additional, Gamero, Mario, additional, Luque, Marco, additional, Mentor, Girlande, additional, Zacasa, Pamela, additional, Homsi, Maysam, additional, Caniza, Miguela A., additional, Kumar, Ambuj, additional, and Mukkada, Sheena, additional
- Published
- 2020
- Full Text
- View/download PDF
22. LINFOHISTIOCITOSIS HEMOFAGOCÍTICA COMO COMPLICACIÓN DE INFECCIÓN POR HEPATITIS A: REPORTE DE CASO.
- Author
-
Sabillón, Alejandra, Muñoz, Eduardo, Shafick Asfura-Caballero, Javier, Lagos, Loriley, and Luque, Marco
- Abstract
Copyright of Revista de Enfermedades Infecciosas en Pediatría is the property of Ediciones Franco S.A. de C.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2022
23. Self-audits as alternatives to travel-audits for improving data quality in the Caribbean, Central and South America network for HIV epidemiology
- Author
-
Lotspeich, Sarah C., primary, Giganti, Mark J., additional, Maia, Marcelle, additional, Vieira, Renalice, additional, Machado, Daisy Maria, additional, Succi, Regina Célia, additional, Ribeiro, Sayonara, additional, Pereira, Mario Sergio, additional, Rodriguez, Maria Fernanda, additional, Julmiste, Gaetane, additional, Luque, Marco Tulio, additional, Caro-Vega, Yanink, additional, Mejia, Fernando, additional, Shepherd, Bryan E., additional, McGowan, Catherine C., additional, and Duda, Stephany N., additional
- Published
- 2019
- Full Text
- View/download PDF
24. Epidemiología del dengue en Centroamérica y República Dominicana
- Author
-
Ávila-Agüero, María L, primary, Camacho-Badilla, Kattia, additional, Brea-Del-Castillo, José, additional, Cerezo, Lizbeth, additional, Dueñas, Lourdes, additional, Luque, Marco, additional, Melgar, Mario, additional, and Rocha, Crisanta, additional
- Published
- 2019
- Full Text
- View/download PDF
25. Triple versus monoterapia antibiótica en apendicitis complicada: ensayo clínico abierto, Instituto Hondureño de Seguridad Social, Tegucigalpa.
- Author
-
Santos, Karen, primary, Lizardo, José, additional, and Luque, Marco T, additional
- Published
- 2019
- Full Text
- View/download PDF
26. La tosferina, enfermedad re-emergente en Honduras
- Author
-
Benitez, Tanny, primary, Calix, Deris, primary, Euceda, Rogelio, primary, Lagos, Gabriela, primary, Rodriguez, Jimmy, primary, Romero Galeano, Sara, primary, Salgado, Ana, primary, Valladares, Milicent, primary, Luque, Marco, primary, Duron, Reyna Maria, primary, and Sierra, Manuel, primary
- Published
- 2018
- Full Text
- View/download PDF
27. Planeamiento estratégico de Ferreycorp S.A.A
- Author
-
Cóndor Colqui, Erick, Férnandez Luque, Marco Antonio, Ibáñez Estrella, José Luis, Rodríguez Corrales, Ana Rosa, Rodríguez Rondinelli, Gisela Margareth, and Aguilar Rengifo, Juan Manuel
- Subjects
Planificación estratégica ,Bienes de capital--Perú - Abstract
El planeamiento estratégico 2016-2020 elaborado para Ferreycorp es una respuesta al desafío de asumir con liderazgo el nuevo escenario que se revela para la industria de bienes de capital en Latinoamérica para los próximos años. La corporación, cuya existencia se remonta a más de 92 años de trayectoria, ha logrado desarrollar capacidades distintivas que no sólo le han permitido afrontar con éxito las diversas coyunturas experimentadas en el Perú, sino también le han brindado la oportunidad de trascender sus operaciones a un nivel internacional, iniciando su incursión en América del Sur y Centroamérica. Para los próximos años, la mayoría de los países de América Latina no sólo seguirán aprovechando sus ventajas comparativas a través de la ejecución de megaproyectos que se encuentran en cartera, sino que también desarrollarán ventajas competitivas a través del plan de diversificación productiva, acontecimientos que ayudarán a dinamizar los sectores económicos claves y otros motores internos. Debido a que este panorama propicia las condiciones favorables para los intereses de Ferreycorp, el presente plan estratégico define los lineamientos para aprovechar las oportunidades a través del despliegue de estrategias para atender a diversos sectores económicos, incluso diferentes de la minería, expandiendo y consolidando su presencia en otros países de América Latina con diferentes ciclos económicos. Los objetivos y estrategias del plan estratégico responden a los intereses de Ferreycorp y se encuentran alineadas a su visión. El camino hacia la visión requiere que la propuesta de valor sea entregada cumpliendo los principios corporativos con el propósito de agregar valor a las operaciones de los clientes, y requiere también que su posición competitiva se fortalezca constantemente con el fin de lograr un impacto positivo en los stakeholders, a contribuir responsablemente al crecimiento de los países donde participa y a generar un retorno atractivo y sostenible para los accionistas. The 2016-2020 strategic planning for Ferreycorp is a response to the challenge of assuming, with leadership, the new opportunities that are emerging in the capital goods industry in Peru and Latin America. The corporation, with over 92 years of reputation, has not only developed distinctive capabilities that allow it to successfully face diverse circumstances and economic cycles, but it has also had the opportunity to spread its operations to international markets, beginning with South and Central America. Over the next few years, most Latin American countries will continue to take advantage of their comparative advantages through the execution of planned mega-projects, and they will also develop competitive advantages through a product diversification plan that will help revitalize key economic sectors and other internal engines of their economies. Because the current environment is conducive to favorable conditions for Ferreycorp, this strategic plan outlines how to take advantage of these opportunities through the deployment of strategies to address various economic sectors, including different mining sectors, to expand and consolidate its presence in other Latin American countries. The objectives and strategies in this document serve the interests of Ferreycorp, and they are aligned to its vision. The designed value proposition rests in the synergies of its subsidiaries to provide comprehensive and differentiated solutions that allow deliver value to customer operations. The path to this vision requires that this proposal be followed, complying with corporate principles to add value to client operations, and it also requires their competitive positioning to be constantly strengthened in order to achieve a positive impact for stakeholders, to contribute to the responsible growth of the relevant countries, and to generate a sustainable and attractive return for shareholders. Tesis
- Published
- 2016
28. Self-audits as alternatives to travel-audits for improving data quality in the Caribbean, Central and South America network for HIV epidemiology.
- Author
-
Lotspeich, Sarah C., Giganti, Mark J., Maia, Marcelle, Vieira, Renalice, Machado, Daisy Maria, Succi, Regina Célia, Ribeiro, Sayonara, Pereira, Mario Sergio, Rodriguez, Maria Fernanda, Julmiste, Gaetane, Luque, Marco Tulio, Caro-Vega, Yanink, Mejia, Fernando, Shepherd, Bryan E., McGowan, Catherine C., and Duda, Stephany N.
- Subjects
DATA quality ,MEDICAL records ,VIRAL load ,DATA entry ,ERROR rates ,HIV - Abstract
Introduction: Audits play a critical role in maintaining the integrity of observational cohort data. While previous work has validated the audit process, sending trained auditors to sites ("travel-audits") can be costly. We investigate the efficacy of training sites to conduct "self-audits." Methods: In 2017, eight research groups in the Caribbean, Central, and South America network for HIV Epidemiology each audited a subset of their patient records randomly selected by the data coordinating center at Vanderbilt. Designated investigators at each site compared abstracted research data to the original clinical source documents and captured audit findings electronically. Additionally, two Vanderbilt investigators performed on-site travel-audits at three randomly selected sites (one adult and two pediatric) in late summer 2017. Results: Self- and travel-auditors, respectively, reported that 93% and 92% of 8919 data entries, captured across 28 unique clinical variables on 65 patients, were entered correctly. Across all entries, 8409 (94%) received the same assessment from self- and travel-auditors (7988 correct and 421 incorrect). Of 421 entries mutually assessed as "incorrect," 304 (82%) were corrected by both self- and travel-auditors and 250 of these (72%) received the same corrections. Reason for changing antiretroviral therapy (ART) regimen, ART end date, viral load value, CD4%, and HIV diagnosis date had the most mismatched corrections. Conclusions: With similar overall error rates, findings suggest that data audits conducted by trained local investigators could provide an alternative to on-site audits by external auditors to ensure continued data quality. However, discrepancies observed between corrections illustrate challenges in determining correct values even with audits. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
29. Building capacity for active surveillance of vaccine adverse events in the Americas: A hospital-based multi-country network
- Author
-
Bravo-Alcántara, Pamela, primary, Pérez-Vilar, Silvia, additional, Molina-León, Helvert Felipe, additional, Sturkenboom, Miriam, additional, Black, Steven, additional, Zuber, Patrick L.F., additional, Maure, Christine, additional, Castro, Jose Luis, additional, Castellano, Vanesa E., additional, Chiarvetti, Lucia, additional, Falcó, Adriana, additional, Gentile, Angela, additional, Guirau, Karina, additional, Carrega, Maria Eugenia Pérez, additional, Rasjido, Susana, additional, Testino, Sofía, additional, Vizzotti, Carla, additional, Avendaño, Marcela, additional, González, Marcela, additional, Lagos, Rosanna, additional, Maturana, Marcelo, additional, Muñoz, Fernando, additional, Saldaña, Adiela, additional, Soza, Guillermo, additional, Álvarez-Olmos, Martha, additional, Sastoque, Luz Amparo, additional, Mezerville, Marcela Hernández-de, additional, Machado, Vicenta, additional, Roverssi, Ileana, additional, Camacho, Angélica Vargas, additional, Luque, Marco Tulio, additional, Mendoza, Liset, additional, Hernández, Renne F. Aquije, additional, Díaz, Maria Esther Castillo, additional, Mamani, Gladys Turpo, additional, Giachetto, Gustavo, additional, Speranza, Noelia, additional, and Zunino, Carlos, additional
- Published
- 2018
- Full Text
- View/download PDF
30. Implementation of a Standardized Data Collection Tool for Febrile Episodes in Childhood Cancer Patients in Central America and the Caribbean
- Author
-
Levy, Jacqueline, Estripeaut, Dora, Camacho, Kattia, Chang, Alicia, Contreras, Johanny, Gamero, Mario, Luque, Marco, Melgar, Mario, Chen, Yichen, Devidas, Meenakshi, Faughnan, Lane, Licona, Sergio, Muniz-Talavera, Himy, and Mukkada, Sheena
- Abstract
Fever is a common sign of infection and is associated with morbidity and treatment delay in childhood cancer patients. A multinational group of physicians identified the need to develop standardized measures to assess and intervene in the quality of care delivery as measured by adherence to the fever management guidelines published by this group in 2020. Our objective was to create an implement a febrile neutropenia registry that included data for quality assessment. Six sites in Central America and the Caribbean implemented a prototype of a Fever Registry for standardized data collection. Variables collected in the registry included demographic information and quality measures like the performance of selected laboratory tests (neutrophil count and blood culture) and time to antibiotic administration. Sites also collected clinical outcomes, including infection diagnosis, microbiologic diagnosis, critical care support requirements, length of hospital stay, and mortality. The initial implementation cohort included one dedicated pediatric oncology center and five oncology services situated within general pediatric hospitals. From September 9, 2021 to December 5, 2022, the six sites contributed 188 fever episodes from 148 unique patients. The maximum number of fever episodes entered for a single patient was 6 episodes. The distribution of cases entered in the database by site ranged between 5 to 54 cases (average patients enrolled per site=25).84.9% of iCRFs(Case Report forms) had complete data. The most common incomplete data fields were: Initial antimicrobial administered (9/175=5.1%), nutritional status (6/181=3.3%), and was urinalysis performed at onset of fever (6/181=3.3%).Implementation strategies were developed incorporating responses to a survey based on the Consolidated Framework for Implementation Research. Infectious diseases specialists, who were the site leads, directed the implementation efforts at each site. The coordinating team encouraged sites to incorporate hematologists/oncologists and data managers as part of the team. However, team composition and internal meeting frequency were at the discretion of the site leads. Every site elected to use a paper data collection tool to facilitate centralized data entry, which was conducted by a data manager in all but one site. Staff at local sites received two initial trainings and a retraining by St. Jude staff to identify eligible patients and complete data fields appropriately. Group meetings with all site leads were conducted monthly to review progress and challenges and for quality assurance. The challenges most cited were personnel limitations for data collection and data entry. Surges exacerbated these challenges in caseloads related to respiratory illnesses, including SARS-CoV-2, influenza, and RSV.Conclusion: This group has created and implemented a tool to facilitate standardized data collection for a common clinical problem. Implementation challenges highlight the role of human resources and simplifying data collection to minimize data entry time. Current efforts include developing interim reports so clinicians can use data to improve the quality of care delivery in real-time. The group is also revising data fields to remove data points that are often unavailable or unnecessary to measure care quality. Project implementation in these six sites exposed opportunities to streamline the data collection system and optimize the implementation process.
- Published
- 2023
- Full Text
- View/download PDF
31. Kawasaki Disease (KD) in Children (Ch) Older Than 5 Years of Age Among 20 Latin American (LA) Countries: A Prospective Multinational Multicenter Study of the REKAMLATINA Network
- Author
-
Ulloa-Gutierrez, Rolando, primary, Garrido-García, Luis M, additional, Estripeaut, Dora, additional, Rodríguez, Francisco J, additional, Saltigeral-Simental, Patricia, additional, Águila, Olguita Del, additional, Miño, Greta, additional, Luque, Marco T, additional, Collia, Adrián, additional, Faugier-Fuentes, Enrique, additional, Marques, Heloisa Helena De Sousa, additional, Álvarez-Olmos, Martha I, additional, Luciani, Kathia, additional, Pirez, María C, additional, Cofre, Fernanda, additional, Camacho-Moreno, German, additional, Gomez, Virgen, additional, Yamazaki-Nakashimada, Marco a, additional, López-Gallegos, Diana, additional, Calvache-Burbano, Angélica, additional, Avila-Aguero, María L, additional, Izquierdo, Giannina, additional, Camacho-Badilla, Kattia, additional, Soriano-Fallas, Alejandra, additional, Valverde, Kathia, additional, Rodriguez-Herrera, Raymundo, additional, Chacon-Cruz, Enrique, additional, Fernández, Antonio, additional, Martínez-Medina, Lucila, additional, Gámez-González, Luisa Berenise, additional, Dueñas, Lourdes, additional, Pérez-Camacho, Paola, additional, Grazioso, Carlos, additional, Franco, Lorena, additional, Bueno, Nora, additional, Beltán, Sandra, additional, Narváez, Jorge a Vázquez, additional, Salgado, Andrea P., additional, Tremoulet, Adriana H., additional, and Members, Study Group, additional
- Published
- 2016
- Full Text
- View/download PDF
32. Derechos mineros ante la ley catastro
- Author
-
Flores Luque, Marco Antonio, Ríos Quinteros, Isaac, and Flores Olivera, Marco Antonio
- Subjects
Legislación minera ,Catastro minero ,Derecho minero - Abstract
El presente trabajo explica la forma sobre cómo se ha venido laborando en el Registro Público de Minería, siendo el resultado de superar muchos retos para obtener el Catastro Minero Nacional desde que se inició. Todo esto para ofrecer un mejor servicio al usuario minero, contribuyendo a la estabilidad del país. Reforzándose y oficializándose con la Ley del Catastro Minero. Esto se debe al gran esfuerzo del Ingeniero Walter Casquino y a todo el personal que trabajó con él, en la actualidad el Ingeniero Díaz Artieda está a cargo del Registro Público de Minería con la responsabilidad de proseguir y concluir el Catastro Minero Nacional de acuerdo con la Ley Nº 26615. Agradezco al gran Dios Supremo que me ha permitido todos estos años realizar la purificación a través del arte de MAHIKARI y trabajar en el Registro Público de Minería participando en la titilación de los Derechos Mineros del país tanto de los petitorios mineros como de los derechos antiguos (denuncios) y en la constitución del Catastro Minero Nacional. Así también como mis padres y maestros por su gran esfuerzo y orientación durante mi formación personal y profesional. Trabajo de suficiencia profesional
- Published
- 1999
33. Sex-based differences in antiretroviral therapy initiation, switching and treatment interruptions: global overview from the International Epidemiologic Databases to Evaluate AIDS (IeDEA)
- Author
-
Giles, Michelle L, Achhra, Amit C, Abraham, Alison G, Haas, Andreas D, Gill, Michael John, Lee, Man Po, Luque, Marco, McGowan, Catherine, Cornell, Morna, Braitstein, Paula, De Rekeneire, Nathalie, Becquet, Renaud, Wools-Kaloustian, Kara, and Law, Matthew
- Subjects
16. Peace & justice ,610 Medicine & health ,360 Social problems & social services ,3. Good health - Abstract
INTRODUCTION In 2015, the World Health Organization recommended that all HIV-infected individuals consider ART initiation as soon as possible after diagnosis. Sex differences in choice of initial ART regimen, indications for switching, time to switching and choice of second-line regimens have not been well described. The aims of this study were to describe first-line ART and CD4 count at ART initiation by sex, calendar year and region, and to analyse time to change or interruption in first-line ART, according to sex in each region. METHODS Participating cohorts included: Southern, East and West Africa (IeDEA-Africa), North America (NA-ACCORD), Caribbean, Central/South America (CCASAnet) and Asia-Pacific including Australia (IeDEA Asia-Pacific). The primary outcomes analysed for each region and according to sex were choice of initial ART, time to switching and time to discontinuation of the first-line regimen. RESULTS AND DISCUSSION The combined cohort data set comprised of 715,252 participants across seven regions from low- to high-income settings. The median CD4 count at treatment initiation was lower in men compared with women in nearly all regions and time periods. Women from North America and Southern Africa were more likely to switch ART compared to men (p 50% of HIV- positive men and women from Southern Africa, East Africa, South and Central America remained on their original regimen. Men were more likely to have a treatment interruption compared with women in low- and middle-income countries from the Asia/Pacific region (p
34. Planeamiento estratégico de Ferreycorp S.A.A
- Author
-
Cóndor Colqui, Erick, Férnandez Luque, Marco Antonio, Ibáñez Estrella, José Luis, Rodríguez Corrales, Ana Rosa, Rodríguez Rondinelli, Gisela Margareth, Cóndor Colqui, Erick, Férnandez Luque, Marco Antonio, Ibáñez Estrella, José Luis, Rodríguez Corrales, Ana Rosa, and Rodríguez Rondinelli, Gisela Margareth
- Abstract
El planeamiento estratégico 2016-2020 elaborado para Ferreycorp es una respuesta al desafío de asumir con liderazgo el nuevo escenario que se revela para la industria de bienes de capital en Latinoamérica para los próximos años. La corporación, cuya existencia se remonta a más de 92 años de trayectoria, ha logrado desarrollar capacidades distintivas que no sólo le han permitido afrontar con éxito las diversas coyunturas experimentadas en el Perú, sino también le han brindado la oportunidad de trascender sus operaciones a un nivel internacional, iniciando su incursión en América del Sur y Centroamérica. Para los próximos años, la mayoría de los países de América Latina no sólo seguirán aprovechando sus ventajas comparativas a través de la ejecución de megaproyectos que se encuentran en cartera, sino que también desarrollarán ventajas competitivas a través del plan de diversificación productiva, acontecimientos que ayudarán a dinamizar los sectores económicos claves y otros motores internos. Debido a que este panorama propicia las condiciones favorables para los intereses de Ferreycorp, el presente plan estratégico define los lineamientos para aprovechar las oportunidades a través del despliegue de estrategias para atender a diversos sectores económicos, incluso diferentes de la minería, expandiendo y consolidando su presencia en otros países de América Latina con diferentes ciclos económicos. Los objetivos y estrategias del plan estratégico responden a los intereses de Ferreycorp y se encuentran alineadas a su visión. El camino hacia la visión requiere que la propuesta de valor sea entregada cumpliendo los principios corporativos con el propósito de agregar valor a las operaciones de los clientes, y requiere también que su posición competitiva se fortalezca constantemente con el fin de lograr un impacto positivo en los stakeholders, a contribuir responsablemente al crecimiento de los países donde participa y a generar un retorno atractivo y sostenible para los accion, The 2016-2020 strategic planning for Ferreycorp is a response to the challenge of assuming, with leadership, the new opportunities that are emerging in the capital goods industry in Peru and Latin America. The corporation, with over 92 years of reputation, has not only developed distinctive capabilities that allow it to successfully face diverse circumstances and economic cycles, but it has also had the opportunity to spread its operations to international markets, beginning with South and Central America. Over the next few years, most Latin American countries will continue to take advantage of their comparative advantages through the execution of planned mega-projects, and they will also develop competitive advantages through a product diversification plan that will help revitalize key economic sectors and other internal engines of their economies. Because the current environment is conducive to favorable conditions for Ferreycorp, this strategic plan outlines how to take advantage of these opportunities through the deployment of strategies to address various economic sectors, including different mining sectors, to expand and consolidate its presence in other Latin American countries. The objectives and strategies in this document serve the interests of Ferreycorp, and they are aligned to its vision. The designed value proposition rests in the synergies of its subsidiaries to provide comprehensive and differentiated solutions that allow deliver value to customer operations. The path to this vision requires that this proposal be followed, complying with corporate principles to add value to client operations, and it also requires their competitive positioning to be constantly strengthened in order to achieve a positive impact for stakeholders, to contribute to the responsible growth of the relevant countries, and to generate a sustainable and attractive return for shareholders., Tesis
35. Planeamiento estratégico de Ferreycorp S.A.A
- Author
-
Cóndor Colqui, Erick, Férnandez Luque, Marco Antonio, Ibáñez Estrella, José Luis, Rodríguez Corrales, Ana Rosa, Rodríguez Rondinelli, Gisela Margareth, Cóndor Colqui, Erick, Férnandez Luque, Marco Antonio, Ibáñez Estrella, José Luis, Rodríguez Corrales, Ana Rosa, and Rodríguez Rondinelli, Gisela Margareth
- Abstract
El planeamiento estratégico 2016-2020 elaborado para Ferreycorp es una respuesta al desafío de asumir con liderazgo el nuevo escenario que se revela para la industria de bienes de capital en Latinoamérica para los próximos años. La corporación, cuya existencia se remonta a más de 92 años de trayectoria, ha logrado desarrollar capacidades distintivas que no sólo le han permitido afrontar con éxito las diversas coyunturas experimentadas en el Perú, sino también le han brindado la oportunidad de trascender sus operaciones a un nivel internacional, iniciando su incursión en América del Sur y Centroamérica. Para los próximos años, la mayoría de los países de América Latina no sólo seguirán aprovechando sus ventajas comparativas a través de la ejecución de megaproyectos que se encuentran en cartera, sino que también desarrollarán ventajas competitivas a través del plan de diversificación productiva, acontecimientos que ayudarán a dinamizar los sectores económicos claves y otros motores internos. Debido a que este panorama propicia las condiciones favorables para los intereses de Ferreycorp, el presente plan estratégico define los lineamientos para aprovechar las oportunidades a través del despliegue de estrategias para atender a diversos sectores económicos, incluso diferentes de la minería, expandiendo y consolidando su presencia en otros países de América Latina con diferentes ciclos económicos. Los objetivos y estrategias del plan estratégico responden a los intereses de Ferreycorp y se encuentran alineadas a su visión. El camino hacia la visión requiere que la propuesta de valor sea entregada cumpliendo los principios corporativos con el propósito de agregar valor a las operaciones de los clientes, y requiere también que su posición competitiva se fortalezca constantemente con el fin de lograr un impacto positivo en los stakeholders, a contribuir responsablemente al crecimiento de los países donde participa y a generar un retorno atractivo y sostenible para los accion, The 2016-2020 strategic planning for Ferreycorp is a response to the challenge of assuming, with leadership, the new opportunities that are emerging in the capital goods industry in Peru and Latin America. The corporation, with over 92 years of reputation, has not only developed distinctive capabilities that allow it to successfully face diverse circumstances and economic cycles, but it has also had the opportunity to spread its operations to international markets, beginning with South and Central America. Over the next few years, most Latin American countries will continue to take advantage of their comparative advantages through the execution of planned mega-projects, and they will also develop competitive advantages through a product diversification plan that will help revitalize key economic sectors and other internal engines of their economies. Because the current environment is conducive to favorable conditions for Ferreycorp, this strategic plan outlines how to take advantage of these opportunities through the deployment of strategies to address various economic sectors, including different mining sectors, to expand and consolidate its presence in other Latin American countries. The objectives and strategies in this document serve the interests of Ferreycorp, and they are aligned to its vision. The designed value proposition rests in the synergies of its subsidiaries to provide comprehensive and differentiated solutions that allow deliver value to customer operations. The path to this vision requires that this proposal be followed, complying with corporate principles to add value to client operations, and it also requires their competitive positioning to be constantly strengthened in order to achieve a positive impact for stakeholders, to contribute to the responsible growth of the relevant countries, and to generate a sustainable and attractive return for shareholders.
36. Outcomes After Second-Line Antiretroviral Therapy in Children Living With HIV in Latin America.
- Author
-
Somerville K, Jenkins CA, Carlucci JG, Person AK, Machado DM, Luque MT, Pinto JA, Rouzier V, Friedman RK, McGowan CC, Shepherd BE, and Rebeiro PF
- Subjects
- Adolescent, Anti-HIV Agents administration & dosage, Brazil epidemiology, Child, Child, Preschool, Female, Haiti epidemiology, Honduras epidemiology, Humans, Male, Treatment Outcome, Viral Load, Anti-HIV Agents therapeutic use, HIV Infections drug therapy, HIV Infections epidemiology, HIV-1
- Abstract
Background: Little is known about the long-term outcomes of children living with HIV in Latin America. Few studies have examined antiretroviral therapy (ART) regimen switches in the years after the introduction of ART in this population. This study aimed to assess clinical outcomes among children who started second-line ART in the Caribbean, Central and South America network for HIV epidemiology., Methods: Children (<18 years old) with HIV who switched to second-line ART at sites within Caribbean, Central and South America network for HIV epidemiology were included. The cumulative incidence and relative hazards of virologic failure while on second-line ART, loss to follow-up, additional major ART regimen changes, and all-cause mortality were evaluated using competing risks methods and Cox models., Results: A total of 672 children starting second-line ART were included. Three years after starting second-line ART, the cumulative incidence of death was 0.10 [95% confidence interval (CI) 0.08 to 0.13], loss to follow-up was 0.14 (95% CI: 0.11 to 0.17), and major regimen change was 0.19 (95% CI: 0.15 to 0.22). Of those changing regimens, 35% were due to failure and 11% due to toxicities/side effects. Among the 312 children with viral load data, the cumulative incidence of virologic failure at 3 years was 0.62 (95% CI: 0.56 to 0.68); time to virologic failure and regimen change were uncorrelated (rank correlation -0.001; 95% CI -0.18 to 0.17)., Conclusions: Poor outcomes after starting second-line ART in Latin America were common. The high incidence of virologic failure and its poor correlation with changing regimens was particularly worrisome. Additional efforts are needed to ensure children receive optimal ART regimens., Competing Interests: P.F.R. has received an honorarium from Gilead. All authors are currently receiving a grant (U01AI069923) from NIH (NICHD, NCI, NIAID, NIMH, and OD); this work was also supported by separate grants from the NIH/NIAID (K01-AI131895, P.F.R.). The remaining authors have no conflicts of interest to disclose., (Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
37. [Epidemiology of dengue in Central America and the Dominican Republic].
- Author
-
Ávila-Agüero ML, Camacho-Badilla K, Brea-Del-Castillo J, Cerezo L, Dueñas L, Luque M, Melgar M, and Rocha C
- Subjects
- Central America epidemiology, Dominican Republic epidemiology, Humans, Incidence, Pan American Health Organization, Dengue epidemiology
- Abstract
Background: Central America experiences a high burden of dengue reporting about 8% of all cases in the continent. This work reports the epidemiology of dengue in the sub region in a 10 years period., Aim: To describe the epidemiology of dengue in Central America and the Dominican Republic., Methods: Study period from 2005 to 2014. The data on dengue cases and deaths of the countries of Central America and the Dominican Republic, reported by the Ministries of Health, were compiled and analyzed and corroborated with the data published in the online bulletins and the interactive database of the Pan American Health Organization (PAHO). Population statistics were obtained from the National Statistics and Census Institutes of each country., Results: During the study period, 1,118,464 cases of dengue were notified. There were 32,431 serious cases reported, 888 people died. The lethality per case of dengue was on average 0.08%. The four dengue serotypes circulated during the decade analyzed., Discussion: Clinical and epidemiological information indicates high incidence rates, which have fluctuated in recent years, with significant co-circulation of several serotypes at the same time., Conclusions: Notorious surveillance data collection differences were identified between countries, determining a heterologous epidemiological pattern.
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.